Clinical Trials in Minneapolis

Showing 6581-6600 of 14,456 trials

Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies

NCT01416428

The purpose of this study is to determine the maximum tolerated dose (MTD), activity, and safety of oprozomib in patients with hematologic malignancies.

Multiple MyelomaWaldenstrom Macroglobulinemia

Amgen210 participantsStarted Oct 2011

Scottsdale, Arizona, United States • Salinas, California, United States • Denver, Colorado, United States +16 more locations

COMPLETEDPhase 2/3< 1 mile

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)

NCT01782989

This is a prospective, randomized study to evaluate the efficacy and safety of ORACEA® in the treatment of geographic atrophy due to dry age-related macular degeneration (AMD).

Geographic Atrophy

Paul Yates, MD, PhD286 participantsStarted Feb 2013

Glendale, California, United States • Poway, California, United States • Golden, Colorado, United States +34 more locations

Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)

Find Trials by Condition in Minneapolis

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy

Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels

Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)

TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment

LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis

A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients

Randomized, Double-Blind, Placebo-Controlled Trial, Followed by Single-Arm Treatment of PRO 140

An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)

Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2)

Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects

A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Diagnostic Accuracy Of Forced Oscillation Technique To Detect Lung Function Anomalies

Brain Correlates of Self-Focused Processing